Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Tokmanni Group - Correction to announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act

Tokmanni Group Corporation (the “Company”) has received a notification from Takoa Invest Oy according to which Takoa Invest Oy's 100% owned subsidiary, Rockers Tukku Oy, has been merged with its parent company Takoa Invest Oy on 31 December 2017 and thus Rockers Tukku’s 17.00% direct holding in Tokmanni Group has been transferred to Takoa Invest Oy. In the release sent earlier today there was a mistake in the title of the table below. The correct title is: Total positions of Takoa Invest Oy: +-----------------+---------+------------------+-----+------------------------+|

Tokmanni Group Corporation - Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act

Tokmanni Group Corporation (the “Company”) has received a notification from Takoa Invest Oy according to which Takoa Invest Oy's 100% owned subsidiary, Rockers Tukku Oy, has been merged with its parent company Takoa Invest Oy on 31 December 2017 and thus Rockers Tukku’s 17.00% direct holding in Tokmanni Group has been transferred to Takoa Invest Oy. Total positions of Rockers Tukku Oy: +-----------------+---------+------------------+-----+------------------------+| |% of   |% of   shares and |Total|Total   number of shares|| |shares |voting

GHP starts new business within Urology

In order to strengthen its position within urology in Stockholm, GHP is starting a urology clinic at Läkarhuset Odenplan in Stockholm. The clinic will be led by Magnus Annerstedt, who is verymuch involved in the field of urology both nationally and internationally and who has state of the art competence in prostate cancer care and robotic surgery. GHP already has Urologcentrum in Liljeholmen in the south of Stockholm. The new clinic at Odenplan will supplement this with a catchment area comprising the center and north of Stockholm.GHP Urologcentrum Odenplan starts on 1 February 2018 and

Board Appointment

ENQUEST PLC, 8 January 2018.Board Appointment EnQuest PLC ('EnQuest') is pleased to announce the appointment of Laurie Fitch as a Non-Executive Director of the EnQuest Board with effect from 8 January 2018. On joining the Board, Laurie Fitch will become a member of the Remuneration and Risk Committees. Laurie has developed an extensive knowledge of the utilities and industrials sectors having worked for more than 20 years in a variety of investment and corporate finance roles. She is currently a partner in the Strategic Advisory Group of PJT Partners. Ms. Fitch is also a member of

BerGenBio to present at Biotech Showcase 2018

Bergen, Norway, 8 January 2018 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective Axl kinase inhibitors for multiple cancer indications, announces that the Company will present a corporate update during the Biotech Showcase 2018 held at the Hilton San Francisco Union Square. The presentation will include a discussion of recent progress across BerGenBio’s phase II clinical trial programme with selective Axl inhibitor BGB324 (bemcentinib).Details of the presentation are as follows: · Date: January 9, 2018 · Time: 10:00 am PST · Room:

CELLINK signs collaboration agreement with CTIBIOTECH for Bioprinting of patient-specific cancer tumors

CTIBIOTECH are leading a new path towards personalized cancer therapies through utilization of CELLINK’s technology platform. By taking a small piece of a patient’s tumor, multiplying the cells, and then bioprinting the patient’s tumor in the laboratory, researchers can discover, understand and find the exact treatment best for the specific cancer. CTIBIOTECH uses 3D bioprinting technologies, including the CELLINK BIO X 3D printing system and bioinks, to advance models and lead the way forward for treating cancer in the future. Professor Colin McGuckin (Founder, CTIBIOTECH) “We are proud

Revenues for the fourth quarter of 2017

Lier, 8 January 2018: Kid ASA today announces unaudited revenue figures for the fourth quarter of 2017 (previous year in brackets). For definition of like-for-like stores, please see latest quarterly report at http://investor.kid.no. · Q4 revenues increased by +4.5% to MNOK 505.5 (MNOK 483.8). Like-for-like sales decreased by -0.2%. Online sales increased by +33.8%. The number of shopping days in the quarter was 76 (78). · For the fiscal year of 2017, revenues increased by +6.8% to MNOK 1,381.7 (MNOK 1,293.9). Like-for-like sales increased by +3.1%. Online sales increased by +35.4%.

Cimco Marine AB (publ) launches 150 hp OXE – production of 200 hp OXE is expected to resume in Q2

Cimco Marine AB (publ) will commence production and delivery of the 150 hp OXE diesel outboard engine this week. During the autumn, the company has worked hard to finalise the 150 hp model. The response from our distributors has been positive.Separately, the root cause for the turbo leakage in the 200 hp OXE has been identified. The production of 200 hp OXE is expected to recommence in Q2.– The launch of 150 hp OXE has been well received by our distributors and end customers. Some of our customers are to convert their 200 hp OXE orders to 150 hp OXE. Overall, of course, it is very

Targovax announces the appointment of Michael Bogenstaetter as Chief Business Officer

Oslo, Norway, 8 January 2018: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that Michael Bogenstaetter has been appointed as the Company's Chief Business Officer (CBO). He will take up this role in January 2018. Michael joins Targovax following 25 years' experience in biotech and big pharma. During this time he held senior business development and strategy positions with Sanofi, Novartis and MDS. Michael has also worked as a consultant with The Boston Consulting Group and,

Scientists uncover why sauna bathing is good for your health

Over the past couple of years, scientists at the University of Eastern Finland have shown that sauna bathing is associated with a variety of health benefits. Using an experimental setting this time, the research group now investigated the physiological mechanisms through which the heat exposure of sauna may influence a person’s health. Their latest study with 100 test subjects shows that taking a sauna bath of 30 minutes reduces blood pressure and increases vascular compliance, while also increasing heart rate similarly to medium-intensity exercise. Previously, the research group has

Millicom acquires spectrum in Paraguay

Luxembourg, January 5th, 2018 - Millicom International Cellular S.A. ("Millicom") announced today that its wholly-owned subsidiary in Paraguay, Telefónica Celular del Paraguay SA (Tigo), has acquired three of the seven available blocks of 2x5MHz spectrum in the 700MHz band at a total cost of $36.325m, plus certain social and network coverage obligations.  Jose Perdomo, General Manager of Tigo Paraguay, commented: “This new spectrum will allow us to cost-effectively continue to expand our 4G network in Paraguay and provide high-speed mobile data services to more Paraguayans. We are proud

Citycon Oyj - Changes in company's own shares

CITYCON OYJ  Stock Exchange Announcement05.01.2018 at 18:35 hrs REPURCHASE OF OWN SHARES Date: 5.1.2018Exchange transaction: Buy Share class CTY1SAmount, shares 30 000Average price/share, EUR 2,1950Total price, EUR 65 850,00 The number of shares heldby Citycon Corporationafter the completion oftransactions: 30000shares. On behalf of CityconCorporation EVLI BANK PLC Lauri Vehkaluoto Further Enquiries: Head of InvestorRelations, Mikko PohjalaTel. +358 40 838

Over-Allotment Option not exercised and end of the stabilization period

Danske Bank A/S, Danmark, Sverige Filial (“Danske Bank”) notifies that the Over-Allotment Option regarding 1,701,819 shares in MAG Interactive AB (publ) (“MAG Interactive” or the “Company”) is not exercised and that stabilization measures have been undertaken in the Company’s shares traded on Nasdaq First North Premier. The stabilization period has now ended and no further stabilization transaction will be effected.As announced in connection with the offering to acquire shares in the Company and the listing of the Company’s shares on Nasdaq First North Premier (the ”Offering”), Danske Bank

#18-22 Recalculation of reference value for certain instruments with Norwegian Air Shuttle ASA as underlying security

Symbol: BEAR NAS NO X5 V Symbol: BEAR NAS NO X5 VON The instruments will be traded under observation for the duration of this trading day. For more information concerning the recalculation, please contact the issuer of the affected instrument.For further information concerning this NGM notice please contact: NGM market surveillance, +46 8 566 390 55, marketsurveillance@ngm.se   Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned

Invitation – DNB’s fourth quarter results for 2017 will be presented on Thursday 1 February

DNB will publish its results for the fourth quarter of 2017 on Thursday, 1 February 2018 at 7.30 am CET. 1 February at 9.30 am CET: press conference in English accessible via live web TVPlace: DNB’s head office in Bjørvika, Dronning Eufemias gate 30, Oslo. A live broadcast will be available on the Investor Relations pages at ir.dnb.no.Please register your attendance in Oslo at ca@dnb.no (ca@dnb.no?Subject=Registration%20DNB%20Quarterly%20Presentation%20Oslo). The press conference will be held in English. 1 February at 1.30 pm CET: conference call for analysts and investorsTo

Planmed Clarity™ 2D digital mammography system receives FDA approval

The United States Food and Drug Administration (FDA) issued an approval letter for the Planmed Clarity™ 2D full-field digital mammography system on December 28th, 2017. The Planmed Clarity 2D system is an elegant digital mammography system, which provides great image quality, optimal ergonomics, and excellent usability for breast cancer screenings. In addition to screening mammograms, the system supports diagnostic work-up examinations and biopsy procedures.According to Jan Moed, Managing Director of Planmed Oy, the FDA approval for the system is an important milestone for the Planmed

Karnov Group completes acquisition of Wolters Kluwer’s legal business in Sweden.

Karnov Group has completed the acquisition of Wolters Kluwer’s Swedish Legal and Regulatory business, hereby strengthening the position in Sweden, making Karnov Group one of the leading suppliers of legal information solutions.The transaction was completed on Thursday, January 4th 2018, at a price of 68 mn EUR. By this acquisition, Karnov Group takes over Wolters Kluwer’s Legal & Regulatory business, which going forward will be named Norstedts Juridik AB. This business area includes the legal solutions Zeteo and Crito as well as the Swedish publishing business. For many years,

Odfjell SE is pleased to announce that Harald Fotland is appointed Chief Operation Officer (COO) effective from 5 January 5 2018.

Odfjell is introducing a COO function to ensure they have full integration between ship management and commercial operations, which is key to delivering top quality service in the chemical tanker industry. With the new structure, Odfjell Tankers will have common and aligned goals across all functions relating to chemical tankers. Harald Fotland joined Odfjell in 2010 as Chief of Staff. In 2015, he was appointed Senior Vice President of Odfjell Tankers, and since January 2017 he also held the position as intermediate Senior Vice President of Odfjell's Ship Management. Fotland is a

Mechanism that converts white fat to brown identified

[PRESS RELEASE 5 January 2018] An international team of researchers led from Karolinska Institutet have, in experiments on mice, pinpointed a mechanism for the conversion of energy-storing white fat into energy-expending brown fat. The study is published in the Journal of Experimental Medicine.Obesity is a major global health issue, affecting all age groups. Obesity increases the risk of several serious human diseases, including cardiovascular disease, type 2 diabetes and cancer. Despite this knowledge, effective drugs for the treatment of obesity and related metabolic disease are lacking.

Konecranes Plc: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

KONECRANES PLC STOCK EXCHANGE RELEASE January 5, 2018  16.00 EETKonecranes Plc: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10Konecranes has on January 5, 2018, received a notification under Chapter 9, Section 5 of the Securities Market Act, according to which the total holding of BlackRock, Inc. in Konecranes Plc’s shares and votes has fallen below 15 percent.On January 4, 2018, BlackRock, Inc.’s total holding through shares and financials instruments amounted to 14.94 percent of Konecranes Plc’s shares and votes.Total positions of BlackRock, Inc.:

Func Food Group Oyj – Additional equity contribution

Published on January 5, 2018 at 14:00 CET. Func Food Group Oyj (the "Company") has on 18 December 2017 given instructions to Nordic Trustee & Agency AB (publ), being the agent under its up to EUR 50,000,000 senior secured callable bond loan with ISIN SE0007186150 2015/2019 (the "Bonds") to initiate a written procedure in order to request that the bondholders vote in favor of amending the terms and conditions of the Bonds to restore the equity position within the group, allow certain changes to be made in the organization and debt structure of the group, and enhance the liquidity position

Biohit Oyj’s comments on its Chinese distributor’s announcement

Biohit Oyj company release 5.1.2018 klo 14:30 local time (EEST) Biohit Oyj does not normally comment on its distributors or other third parties announcements, but due to details presented in the media and the potential effects this may have on the company’s share price Biohit Oyj gives out the following statement: Biohit Oyj’s distributor, a wholly Chinese owned Biohit HealthCare (Hefei) Co. Ltd has announced that it will expand its GastroPanel production capacity and that it will bring GastroPanel onto new technology platforms and instruments. The announced investment to increase the

Eltel increases Finnish domestic commercial paper program to EUR 150 million

Eltel AB has increased the Finnish domestic commercial paper program, signed in September 2015, to EUR 150 million. The program facilitates issuance of commercial papers with tenors less than one year for working capital and other short term funding purposes.The banks involved in the transaction in Finland are Danske Bank, OP Corporate Bank, SEB and Swedbank. For further information:Petter Traaholt, CFOTel. +46 72 595 4749, petter.traaholt@eltelnetworks.se ) About Eltel Eltel is a

There are no items matching the current filter
There are no more items matching the current filter
Back to top